Home>Topics>Stocks>Isis Pharmaceuticals

Isis Pharmaceuticals ISIS

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Global Equities 2015: Fasten Your Seat Belt for a Multi-Speed World

      Headlines

      Tue, 27 Jan 2015

      disparities are still pronounced, is also important. The list goes on. And there are new global challenges such as the rise of ISIS and cyber-terrorism. So while there are very real improvements and challenges for global economic growth in the ongoing recovery

    2. J&J buys bowel drug license option from Isis Pharma for $835 mln

      Headlines

      Mon, 5 Jan 2015

      Jan 5 (Reuters) - Johnson & Johnson will pay Isis Pharmaceuticals Inc up to $835 million for the option to license three drugs targeting autoimmune diseases in the bowel.

    3. Isis ’ Deal with J&J Underlines Broad Potential of its Antisense Technology; Increasing FVE

      Commentary

      Mon, 5 Jan 2015

      increasing our fair value estimate for Isis to $54 per share (from $50) following ..... commercialization costs for the optioned drugs. Isis will receive a $35 million upfront payment ..... products. This deal is consistent with Isis ’ previous partnerships with Big Pharma

    4. The Forecast: All Wrong

      Headlines

      Sun, 28 Dec 2014

      There were talk about valuations or price/earnings ratios being too high, concern about the war in Ukraine (terrorist group ISIS wasn’t even in the headlines yet), and endless noise about unfavorable weather patterns impacting the market. So has 2014

    5. Lessons from 2014

      Headlines

      Fri, 19 Dec 2014

      patience. Geopolitical events, such as the Russia-Ukraine conflict and the emergence of the Islamic State (also known as ISIS or ISIL), took investors’ eyes off the ball and kept many on the sidelines. The media did a great job of exaggerating the

    6. A Practical Approach to Tech Investing

      Headlines

      Thu, 4 Dec 2014

      With the nervousness over geopolitical concerns, including a slowdown in the eurozone, ISIS in the Middle East and the US mid-term elections, we weren’t surprised to see volatility rile the stock market this fall

    7. How the Long Bond Stole the Trophy

      Headlines

      Thu, 4 Dec 2014

      forced to reconsider the risks and rewards within fixed income in light of global economic challenges and geopolitical events ( ISIS , Russia/Ukraine tensions, Ebola). All told, valuations on several metrics have become rich. It would not be surprising

    8. Value Matters

      Headlines

      Mon, 17 Nov 2014

      quantitative easing’ stimulus. Investors have generally shrugged off world events that might otherwise cause high anxiety ( ISIS and the Middle East, Russia and Ukraine, etc.). As attention now turns to when the Fed will raise short-term interest rates

    9. How the Long Bond Stole the Trophy

      Headlines

      Fri, 14 Nov 2014

      forced to reconsider the risks and rewards within fixed income in light of global economic challenges and geopolitical events ( ISIS , Russia/Ukraine tensions, Ebola). All told, valuations on several metrics have become rich. It would not be surprising

    10. A Downside Surprise in October Jobs Report?

      Video Reports

      Thu, 6 Nov 2014

      consumer spending? What's holding that back? Johnson: That's a hard one. Maybe it's some of the headline events like ISIS and maybe it was some fears of what's going on there. But it's really kind of hard to explain. It's one of the great

      ISIS found at 4:16

      That's a hard one. Maybe it's some of the headline events like ISIS and maybe it was some fears of what's going on there. But it's really kind of hard to explain. It's one of
    « Prev12345Next »
    Content Partners